Accéder au contenu
Merck

FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2007-12-28)
Usha Narayanan, Vijayalaxmi Nalavadi, Mika Nakamoto, David C Pallas, Stephanie Ceman, Gary J Bassell, Stephen T Warren
RÉSUMÉ

Fragile X syndrome is a common form of inherited mental retardation and is caused by loss of fragile X mental retardation protein (FMRP), a selective RNA-binding protein that influences the translation of target messages. Here, we identify protein phosphatase 2A (PP2A) as an FMRP phosphatase and report rapid FMRP dephosphorylation after immediate group I metabotropic glutamate receptor (mGluR) stimulation (<1 min) in neurons caused by enhanced PP2A enzymatic activity. In contrast, extended mGluR activation (1-5 min) resulted in mammalian target of rapamycin (mTOR)-mediated PP2A suppression and FMRP rephosphorylation. These activity-dependent changes in FMRP phosphorylation were also observed in dendrites and showed a temporal correlation with the translational profile of select FMRP target transcripts. Collectively, these data reveal an immediate-early signaling pathway linking group I mGluR activity to rapid FMRP phosphorylation dynamics mediated by mTOR and PP2A.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Kit pour essais sur la Ser/Thr phosphatase 1 (K-R-pT-I-R-R), Ser/Thr Phosphatase Assay Kit 1used to detect PP2A activity by either dephosphorylation of the phosphopeptide.